We explored the correlation of baseline PAX1 methylation status with clinical outcomes including age, FIGO stage, pathological type, HPV status, lymph node metastasis, tumor size and short-term efficacy. The gene discussed is PAX1; the disease is metastatic malignant neoplasm in the lymph nodes.